FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

5501111000001108: Moxonidine 400microgram tablets 30 tablet (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
22935501000001117 Moxonidine 400microgram tablets 30 tablet (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
22935601000001118 Moxonidine 400microgram tablets 30 tablet en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Moxonidine 400microgram tablets 30 tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Moxonidine 400microgram tablets 30 tablet Is a Virtual medicinal product pack true Inferred relationship Existential restriction modifier
Moxonidine 400microgram tablets 30 tablet Is pack of Product containing precisely moxonidine 400 microgram/1 each conventional release oral tablet false Inferred relationship Existential restriction modifier
Moxonidine 400microgram tablets 30 tablet Has active ingredient Moxonidine false Inferred relationship Existential restriction modifier
Moxonidine 400microgram tablets 30 tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Moxonidine 400microgram tablets 30 tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Moxonidine 400microgram tablets 30 tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Moxonidine 400microgram tablets 30 tablet Has VMP Product containing precisely moxonidine 400 microgram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Moxonidine 400microgram tablets 30 tablet Has specific active ingredient Moxonidine true Inferred relationship Existential restriction modifier
Moxonidine 400microgram tablets 30 tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Moxonidine 400microgram tablets (PI) (Dowelhurst Ltd) 30 tablet 3 x 10 tablets Is a True Moxonidine 400microgram tablets 30 tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start